Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
dalpiciclib plus letrozole
DRUG
2 trials
Sponsors
The Affiliated Hospital of Qingdao University
, Fengzhi Feng
Conditions
Breast Cancer
Recurrent Ovarian Carcinoma
Phase 2
Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer
NCT05512416
The Affiliated Hospital of Qingdao University
Breast Cancer
Start: 2022-08-31
End: 2024-05-31
Target: 35
Updated: 2022-08-23
Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors
Recruiting
NCT06243185
Fengzhi Feng
Recurrent Ovarian Carcinoma
Start: 2023-11-17
End: 2025-06-30
Target: 30
Updated: 2024-02-06